Evidence map›Paper›PMID 36614402›Full record

ArticleMaterials (Basel, Switzerland)2022

Synthesis of Octacalcium Phosphate Containing Glutarate Ions with a High Incorporation Fraction.

Taishi Yokoi, Masahiro Watanabe, Tomoyo Goto, Sikun Meng, Tohru Sekino, Masaya Shimabukuro, Masakazu Kawashita

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Development of bioinspired damage-tolerant calcium phosphate bulk materials.Science and technology of advanced materials · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Taishi YokoiInstitute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU), 2-3-10 Kanda-Surugadai, Chiyoda-ku, Tokyo 101-0062, Japan.ORCID 0000-0002-8519-8153
Masahiro WatanabeInstitute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU), 2-3-10 Kanda-Surugadai, Chiyoda-ku, Tokyo 101-0062, Japan.
Tomoyo GotoSANKEN (The Institute of Scientific and Industrial Research), Osaka University, 8-1 Mohogaoka, Ibaraki, Osaka 567-0047, Japan.ORCID 0000-0003-1362-6750
Sikun MengInstitute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU), 2-3-10 Kanda-Surugadai, Chiyoda-ku, Tokyo 101-0062, Japan.
Tohru SekinoSANKEN (The Institute of Scientific and Industrial Research), Osaka University, 8-1 Mohogaoka, Ibaraki, Osaka 567-0047, Japan.ORCID 0000-0002-6605-9166
Masaya ShimabukuroInstitute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU), 2-3-10 Kanda-Surugadai, Chiyoda-ku, Tokyo 101-0062, Japan.ORCID 0000-0002-0364-8721
Masakazu KawashitaInstitute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU), 2-3-10 Kanda-Surugadai, Chiyoda-ku, Tokyo 101-0062, Japan.

Funding

Japan Society for the Promotion of Science 22H03948Japan Society for the Promotion of Science 22H04500Japan Society for the Promotion of Science 22K19911
6 · The paper itself

Abstract

Octacalcium phosphate (OCP) has received considerable attention in the field of ceramic biomaterials as an advanced functional material. It exhibits a layered structure composed of apatitic and hydrated layers and can incorporate various dicarboxylate ions into the hydrated layer. Saturated dicarboxylic acids (HOOC(CH

Indexed as

glutarate ionincorporationoctacalcium phosphate

Identifiers

PMID36614402
PMCPMC9821757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.